Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Pro4-9 Aurl 9
Pro4-9 Aurl 9
uricasa
ác. úrico + H2O + O2 alantoína + CO2 + H2O2
POD
2 H2O2 + 4-aminoantipirina + 3,5-dicloro-2-hidroxi-sulfonato derivado quinónico coloreado + 4 H2O
uricase
uric acid + H2O + O2 allantoin + CO2 + H2O2
POD
2 H2O2 + 4-aminoantipyrine + 3,5-dichloro-2-hydroxy-sulphonate colored quinonic derivative + 4 H2O
Single test result cannot be used to make a clinical diagnosis. It should integrate clinical Standard -- 0.02 --
and laboratory data.
Working Reagent 1.00 1.00 1.00
REAGENTS
Mix well and let stand for 10 min at 37ºC, read absorbance.
Kit 1 x 100 mL. (Ref. 99 40 22). Contents:
A. 1 x 100 mL Reagent. Ref. 99 40 25 Reading:
B. 1 x 5 mL Standard. Ref. 99 02 63 Wavelength: 546, 505 nm.
Blank: the contents of BL.
Kit 3 x 100 mL. (Ref. 99 40 20). Contents: Colour stability: 30 min (When protected from direct sunlight)
A. 3 x 100 mL Reagent. Ref. 99 40 25
B. 1 x 5 mL Standard. Ref. 99 02 63 CALCULATIONS
SA Abs.
Kit 2 x 250 mL. (Ref. 99 40 15). Contents: x 5 = mg of Uric acid / dL
A. 2 x 250 mL Reagent. Ref. 99 01 48 ST Abs.
B. 1 x 5 mL Standard Ref. 99 02 63
SI Units
(mg/dL) x 59.5 = μmol/L
WORKING REAGENT PREPARATION
The reagent and standard are ready to use.
REFERENCE VALUES
Serum and plasma: Men: 3,5 - 7,2 mg/dL; Women: 2,6-6 mg/dL; Children: 2-5 mg/dL
REAGENT COMPOSITION
Urine 24 hours: 250 - 750 mg/dL.
The reagent composition is as follows:
Pipes buffer pH 7.0 100 mM
Each particular laboratory should establish its own normal range, obtained from samples
l 3,5-dichloro-2-hydroxy-sulphonate 3.2 mM
of a representative population, using its own instrumentation, blood collection methods and
4-aminoantipyrine 0.4 mM assaying procedures.
EDTA Na2·H2O 0.6 mM
K3Fe(CN)6 0.1 mM PERFORMANCE CHARACTERISTICS
a Uricase ≥ 350 U/L The performance characteristics depend on the method used. It is recommended to calcu-
Peroxidase ≥ 1300 U/L late these data for each particular test protocol. These results have been obtained using a
Non reactive stabilizers manual method.
Standard: Aqueous solution of uric acid equivalent to 5 mg/dL. (297.5 μmol/L). Sensitivity, as detection limit: 0.04 mg/dL
s Linearity: Up to 25 mg/dL. For higher values, it is recommended to dilute the sample 1/2 in
STORAGE AND STABILITY saline (NaCl 0.9%) and assay once again. Multiply the final result by 2.
The components of the kit, stored at 2-8ºC, will remain stable until the expiration date stated Accuracy: 105 %.
o on the label. Protect from sunlight. Repetitivity, as Variation Coefficient: 0.7%
Reproducibility, as Variation Coefficient: 3.17%
Signs of reagent deterioration: Reagent turbid or with visible particles. Trueness: Results obtained with this reagent did not show systematic differences when
Reagent blank: ≥ 0.400 compared with reference reagent.
s Details of the performance studies are available on request
ADDITIONAL EQUIPMENT
Spectrophotometer, automated analyser or photometer with thermostated cuvette (37ºC). INTERFERENCES
Light path cuvette: 1 cm. Haemoglobin concentrations higher than 100 mg/dL interfere the assay, as well as bilirubin
y General laboratory equipment. concentrations higher than 15 mg/dL.
.
s SAMPLE QUALITY CONTROL
Serum, plasma or urine samples are stable 4 days at 2-8ºC. Control serum, Seriscann Normal (Ref. 99 41 48) and Seriscann Anormal (Ref. 99 46 85)
Urine samples should be diluted 1/10 with deionised water prior to assay. The final result should be included in each test series. Each particular laboratory should establish its own
should be multiplied by 10. control program.
CAUTION AUTOANALYZERS
The reagent contains sodium azide at 0.09%. Handle with care. Adaptations to different autoanalyzers are available on request.
The safety statements are on the label. It is advisable to look at the SDS before using the
reagent. REFERENCES
The disposal of the residues has to be made according to local regulations. Trinder,P. (1969). Ann.Clin.Biochem., 6, 24 - 27.
Trivedi, R., Rebar, L., Berta, E., Stong, L., (1978), Clin. Chem., 24, 1908-1911.
Fossati, P., Prencipe, L., Berti, G., (1980). Clin. Chem., 26, 227 - 231.
. Klose, S., Stoltz, M., Munz, E., Portenhauser, R., (1978), Clin.Chem, 24, 250-255.
Desideri G., (2014), Europ. Rev. for Med. and Pharmac Scien.,18, 1295-1306.
Tietz, NW., Textbook of Clinical Chemistry 5th Edition, W.B. Saunders, Philadelphia (2012).
CLSI Guidelines and Standards, CLSI, Wayne, P.A
Young D.S., Effect of drugs on Clinical Lab. Test, 5th Ed. AACC Press (2000).
PRINCIPE
L’ac. urique de l’échantillon se dégrade sous l’action de l’uricase d’allantoïne avec une libération d’eau oxygénée. La quantification de l’eau oxygénée libérée est réalisée par le biais de
la réaction de Trinder, au cours de laquelle un composé quinonique coloré est formé par réaction avec la 4-aminoantipyrine et le chromogène 3,5-dichloro-2-hydroxysulfonate en présence
de peroxydase (POD).
La couleur produite au cours de la réaction est proportionnelle à la concentration d’ac. urique de l’échantillon dans des conditions de dosage optimales.
uricase
ac. urique + H2O + O2 allantoïne + CO2 + H2O2
POD
2 H2O2 + 4-amino-antipyrine + 3,5-dichloro-2-hydroxy-sulfonate dérivé quinonique coloré + 4 H2O
H315,H319
P264,P280,P302+P352,P305+P351+P338,P321,P337+P313,P362+P364
ES - ÁCIDO ÚRICO LÍQUIDO, REACTIVO
Atención
Peligro: Provoca irritación cutánea. Provoca irritación ocular grave.
Precaución: Lavarse concienzudamente tras la manipulación. Llevar guantes/prendas/gafas/
máscara de protección. EN CASO DE CONTACTO CON LA PIEL: Lavar con abundante agua.
EN CASO DE CONTACTO CON LOS OJOS: Aclarar cuidadosamente con agua durante varios
minutos. Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando. Se necesita un
tratamiento específico. Si persiste la irritación ocular: Consultar a un médico. Quitar las prendas
contaminadas y lavarlas antes de volver a usarlas.
GB - URIC ACID LIQUID, REAGENT
Warning
Hazard: Causes skin irritation. Causes serious eye irritation.
Precautionary: Wash thoroughly after handling. Wear protective gloves/protective clothing/eye
protection/face protection. IF ON SKIN: Wash with plenty of water. IF IN EYES: Rinse cautiously
with water for several minutes. Remove contact lenses, if present and easy to do. Continue
rinsing. Specific treatment. If eye irritation persists: Get medical advice/attention. Take off conta-
minated clothing and wash it before reuse.
PT - ÁCIDO ÚRICO LIQUIDO, REAGENTE
Atenção
Perigo: Provoca irritação cutânea. Provoca irritação ocular grave.
Precaução: Lavar cuidadosamente após manuseamento. Usar luvas de protecção/vestuário
de protecção/protecção ocular/protecção facial. SE ENTRAR EM CONTACTO COM A PELE:
lavar abundantemente com água. SE ENTRAR EM CONTACTO COM OS OLHOS: enxaguar
cuidadosamente com água durante vários minutos. Se usar lentes de contacto, retire-as, se tal
lhe for possível. Continuar a enxaguar. Tratamento específico. Caso a irritação ocular persista:
consulte um médico. Retirar a roupa contaminada e lavá-la antes de a voltar a usar.
FR - ACIDE URIQUE LIQUIDE, RÉACTIF
Attention
Danger: Provoque une irritation cutanée. Provoque une sévère irritation des yeux.
Précaution: Se laver soigneusement après manipulation. Porter des gants de protection/des
vêtements de protection/un équipement de protection des yeux/du visage. EN CAS DE CON-
TACT AVEC LA PEAU: Laver abondamment à l'eau. EN CAS DE CONTACT AVEC LES YEUX:
rincer avec précaution à l'eau pendant plusieurs minutes. Enlever les lentilles de contact si la
victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer. Traitement spé-
cifique. Si l'irritation oculaire persiste: consulter un médecin. Enlever les vêtements contaminés
u et les laver avant réutilisation.
-
B
ES - ÁCIDO ÚRICO ENZIMÁTICO, ESTÁNDAR 5 MG/DL
GB - URIC ACID ENZYMATIC, STANDARD 5 MG/DL
,
PT - ÁCIDO ÚRICO ENZIMÁTICO, STANDARD 5 MG/DL
FR - ACIDE URIQUE ENZYMATIQUE, STANDARD 5 MG/DL
—
r
)
s